Skip to main content
Caplight Logo









LUCA Science

LUCA Science

Private
TokyoHealthcare & Life Scienceshttps://www.luca-science.com/

Last Round

Series B

Jun 6, 2022

Total Funding Raised

$40.1M

Company Overview

LUCA Science is a biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs by enhancing and stabilizing mitochondrial activity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

mitochondrial therapymitochondrial medicinecellular therapymitochondrial isolationregenerative medicinebiotech startupdrug discoverymitochondrial functionclinical developmentbiopharmamitochondrial diseasetherapeutic pipelinepreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LUCA Science Comparables

Compare LUCA Science with similar companies based on industry and business-model similarity.

LUCA Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
cellvie
81%
PAEAN Biotechnology
81%
Astellas Pharma Inc.
81%

LUCA Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 6, 2022
Series AAug 31, 2020

Key People

Founding team and executive leadership

Yoshikazu Tokuoka

Chief Financial Officer

Executive Team

LUCA Science Investors

Notable investors and investment history

LUCA Science investors
InvestorRounds
Daiwa Securities GroupSeries B
Shinsei Capital PartnersSeries B
DCI PartnersSeries B
日本ベンチャーキャピタル株式会社Series B, Series A
Remiges VenturesSeries B, Series A
4BIO CapitalSeries B
Nissay CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2020

    $10M round led by Axil Capital

LUCA Science Filings

Explore SEC and related filing metadata, where available.

LUCA Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LUCA Science's valuation, stock price, and market status.

Is LUCA Science a public or private company?

LUCA Science is a private company.

What is the current stock price of LUCA Science?

LUCA Science is a private company with no public stock price. No recent secondary market data is available.

How much is LUCA Science worth (valuation)?

Valuation information for LUCA Science is not publicly available.

Can I buy LUCA Science stock?

LUCA Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LUCA Science's last funding round?

LUCA Science's most recent funding round was Series B on June 6, 2022.

Who are the main investors in LUCA Science?

Key investors in LUCA Science include DCI Partners, 4Bio Capital, Axil Capital Partners, Fast Track Initiative.

Will LUCA Science IPO soon?

No public IPO plans have been announced for LUCA Science.

How can I track LUCA Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LUCA Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range8
Year Founded2018
Last FundingJun 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?